Tris Pharma data breach

Clerk's notes

Tris Pharma, a pharmaceutical company specializing in prescription medications, officially reported a data security incident to the Indiana Attorney General on December 4, 2025. The company stated that this incident involved unauthorized access to its systems, an event that occurred on or about September 24, 2025.

As a healthcare-adjacent entity, Tris Pharma routinely handles and stores sensitive information. The reported unauthorized access means that personal information maintained within their systems may have been compromised. While the specific types of data exposed were not detailed, the incident could affect individuals whose data was stored by the company.

If you have received a data breach notification letter from Tris Pharma, it indicates that your personal information was likely among the data involved in this incident. It is crucial to carefully read this notification for any specific details provided by the company regarding the breach and the recommended protective measures.

To help protect yourself, it's advisable to monitor your financial and medical accounts for any unusual or suspicious activity. Be cautious of unsolicited communications, such as emails or phone calls, that request personal information, as these could be phishing attempts. Consider placing a fraud alert or credit freeze on your credit reports.

The incident is currently under investigation. For individuals concerned about the potential impact of this data breach, understanding your rights and options is an important next step. Legal avenues may be available to address the potential harms caused by such data security failures.

If you believe your personal information was compromised in the Tris Pharma incident, you may be entitled to a case review. Requesting a free, no-obligation case review can help determine your eligibility for potential legal action related to this data breach.

If a notification letter about this breach reached you, see every Indiana data breach on file or browse all cases.